Log inGet Started

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC

AI Summary1 min read

TL;DR

Eli Lilly has reduced the cash prices of Zepbound weight loss drug vials on its direct-to-consumer site, with costs dropping to as low as $299 per month. This price cut follows a deal and aims to make the medication more accessible to consumers.

Tags

Eli LillyZepboundweight loss drugprice cutdirect-to-consumer
  1. Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site  CNBC
  2. Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials | Eli Lilly and Company  Eli Lilly and Company
  3. Weight-Loss Drug Zepbound Cost Drops To $299 A Month After Trump Deal  Forbes
  4. Eli Lilly cuts price for popular weight-loss drug Zepbound  USA Today
  5. Eli Lilly lowers starting dose costs for Zepbound on direct purchase platform (LLY:NYSE)  Seeking Alpha

Visit Website